Obalon Obtains Two New U.S. Patents Covering Its Proprietary Intragastric Balloon System
July 16 2019 - 8:30AM
Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated
medical technology company with the first and only FDA-approved
swallowable, gas-filled intragastric balloon system for the
treatment of obesity, announced that the U.S. Patent and Trade
Office has issued the Company two new patents: U.S. Patent No.
10,327,936 and U.S. Patent No. 10,335,303. The newly issued patents
provide additional coverage for Obalon’s proprietary intragastric
balloon system and specific technological components. The
issued patent claims include an encapsulated gastric balloon with a
push catheter assembly to aid balloon placement in patients that
may not be able to easily swallow the capsule, and the Company’s
innovative self-sealing valve system that is critical to enabling
the use of gas to fill the balloon.
Obalon now has 22 patents issued in the U.S. and 31 patents
issued internationally covering the Company’s proprietary Obalon
Balloon System and 24 and 55 patent applications pending in the
U.S. and international territories, respectively.
“These patents add to the intellectual property portfolio
covering our swallowable, gas-filled intragastric balloon system in
the U.S.,” said Mark Brister, Obalon’s Chief Technology Officer.
“We believe that our novel technology platform featuring the Obalon
Balloon, Obalon Navigation System™, and our Obalon Touch® Inflation
Dispenser significantly differentiates our product offering from
liquid-filled intragastric balloons.”
About Obalon Therapeutics, Inc. Obalon
Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company
focused on developing and commercializing novel technologies for
weight loss. For more information, please
visit www.obalon.com.
For Obalon Therapeutics, Inc.
Investor Contact:William PlovanicPresident & Chief Financial
OfficerObalon Therapeutics, Inc.Office: +1 760 607
5103wplovanic@obalon.com
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Apr 2023 to Apr 2024